CellCarta Forms Global Digital Pathology and AI Consortium
CellCarta has launched its Global Digital Pathology and AI Consortium, announced in a press release. The initiative brings together technology partners including Lunit, Mindpeak, Imagene AI, Dipath AI, Nucleai, Tivenix, and Indica Labs to create a shared ecosystem for AI and digital pathology collaboration.
The consortium aims to give biopharma sponsors access to AI tools and digital pathology workflows for biomarker discovery, patient stratification, and companion diagnostic development. It covers oncology, autoimmune disorders, Alzheimer’s disease, and other indications.
CellCarta said the model is designed to be flexible and AI agnostic, allowing participants to evaluate and deploy multiple AI technologies through one coordinated infrastructure. This approach integrates digital pathology, image analysis, proteomics, genomics, and regulatory capabilities in one system for clinical and translational research programs.
The program will continue to evolve as more partners and technologies are added to support emerging disease areas and new biomarker strategies.
We hope you enjoyed this article
Consider subscribing to one of our newsletters like Life AI Weekly or Daily AI Brief.
Also, consider following us on social media:
More from Life Sciences
Oct 16 Study Tests Smartphone AI for Children's Lung Sounds Oct 16 Manhattan Physician Invests in RunPractice Oct 16 Attilio appoints Buck Institute CEO Eric Verdin as cochairman Oct 16 Aignostics launches HETA Clinical for pathology workflows Oct 16 Specialty1 Partners Invests in AI for Dental Practice OperationsLife AI Weekly
Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.
Whitepaper
Tensordyne Napier: What If One Rack Could Do the Work of Nine?
Tensordyne
This Tensordyne whitepaper presents Napier, an inference-focused AI processor and rack-scale system based on the company’s TDN Math logarithmic number system. It examines infrastructure requirements for large mixture-of-experts and agentic models, compares major inference architecture approaches, and details the TDN AIP processor, TDN72 pod, TDN Link fabric, and Napier Ultra configuration. The paper reports simulation-based performance, cost, and accuracy-validation results, including Tensordyne’s projected comparison of one Napier rack with a nine-rack Nvidia Rubin plus Groq deployment; the chip is reported as taped out and in fabrication.
Read moreYou may also like
Cellular Intelligence Adds Yann LeCun and Three Scientists to Advisory Board
Linearis Joins Two Canadian AI Health Data Projects
Basecamp Research Raises $140 Million for AI Designed Therapeutics
Danaher Plans AI Autonomous Lab for Antibody Research
MediSights Reports Study Using AI Agents for Myeloma Market Research
Daily AI Brief: the AI news that matters, in your inbox.